OrthoPediatrics Corp. (KIDS) is a Medical/Dental Instruments company listed on NASDAQ. In the last 30 days Quantisnow tracked 9 wire items for KIDS, including 4 press releases and news items, 3 SEC filings and 2 earnings updates. The most recent was published Nov 2, 2026.
KIDS rankings
Financial highlights
Full financials- Revenue, TTM
- $264.14M
- Revenue growth
- +16.1%
- Net income, TTM
- -$33.88M
- Net margin
- -12.8%
- Free cash flow, TTM
- $3.18M
- Cash
- $17.14M
For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.
News · 26 weeks42+167%
2026-05-102026-11-01
Mix2290d
- Insider9(41%)
- Other7(32%)
- SEC Filings4(18%)
- Earnings2(9%)
Latest news
25 items- PROrthoPediatrics to Participate in Upcoming ConferencesWARSAW, Ind., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that it will participate in two upcoming investor conferences, held in New York, NY. Event: Stifel 2026 Healthcare ConferenceFormat: Fireside ChatDate: Wednesday, November 11, 2026Time: 10:00 am ET Event: Piper Sandler 38th Annual Healthcare ConferenceFormat: Fireside ChatDate: Wednesday, December 2, 2026Time: 4:00 pm ET An audio webcast of the discussions will be available online at the OrthoPediatrics’ investor relations website, http://ir.orthopediatrics.com. Additionall
- SECSEC Form 10-Q filed by OrthoPediatrics Corp.10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECSEC Form 8-K filed by OrthoPediatrics Corp.8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECSEC Form 8-K filed by OrthoPediatrics Corp.8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First ImplantationsWARSAW, Ind., Oct. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced U.S. Food and Drug Administration (FDA) clearance of the Pediatric Nailing Platform (PNP) | Femur Retrograde Nail System ("PNP Retrograde") and the successful completion of the first procedures using the system. Developed in collaboration with a team of pediatric orthopedic surgeons, the system was designed specifically for pediatric anatomy to address an important unmet market need and includes anatomic nails for trauma and straight nails for deformity. PNP Retrograde builds
- PROrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial GuidanceRecord Third Quarter 2026 Revenue of $72.7 Million, Up 19% Year-over-Year WARSAW, Ind., Oct. 27, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the third quarter ended September 30, 2026. Third Quarter 2026 and Recent Business Highlights Helped nearly 42,000 children in the third quarter of 2026Generated new record high total revenue of $72.7 million for the third quarter of 2026, up 19% from $61.2 million in the third quarter of 2025; domestic revenue increased 19% and international revenue increased 18% in th
- PRPRISM MarketView Highlights Five Innovative Public Companies Supporting Strength and Mobility for National Physical Therapy MonthOrthoPediatrics, Omada Health, Enovis, Myomo and FIGS span the full arc of physical therapy, from childhood care and prevention to recovery and the professionals who deliver it NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) -- PRISM MarketView, a financial media platform covering small and micro-cap public companies, today published a feature marking National Physical Therapy Month. This year’s theme from the American Physical Therapy Association, "PT For Future Me," focuses on building strength, mobility and resilience across a lifetime to extend health span, the years people spend healthy and free of preventable chronic disease. PRISM’s feature highlights five public companies working on di
- PROrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026WARSAW, Ind., Oct. 13, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2026 financial results on Tuesday, October 27, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 27, 2026 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be a
- PROrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIXWARSAW, Ind., Oct. 07, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing ("OPSB") portfolio with a new product launch, the OPSB® Knee 'TractorFIX contracture management orthosis. Knee 'TractorFIX is a first-of-its-kind pediatric bracing solution intended to treat knee contractures, pre-existing or developing, in pediatric patients approximately 2 to 21 years of age who are undergoing tibial treatment with an external fixator. The brace connects directly to the external fixator to support contr
- PROrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques CourseWARSAW, Ind., Oct. 01, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it sponsored the 10th Pediatric Orthopedic Surgical Techniques (POST) Course, which brought together a record 39 participants from 23 institutions across 22 cities and three countries. OrthoPediatrics’ President & CEO, David Bailey, commented, "I want to thank the Armstrong Children’s Orthopedic Alliance for their dedication to advancing pediatric orthopedic education worldwide. As the primary and Platinum Sponsor, OrthoPediatrics’ support was instrumental in bringing the 10t
- PROrthoPediatrics Surpasses 1,000 PNP Tibia Nail ImplantationsWARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000th Tibia Nail using its latest Pediatric Nailing Platform (PNP). The PNP Tibia System was designed to bring a world-class, pediatric-focused nailing system to surgeons, enabling the use of rigid tibial nails in pediatric patients. OrthoPediatrics’ introduction of the 7mm cannulated rigid tibial nail, the only product of its size, enables surgeons to treat patients who have previously been untreatable with adult systems. In fact, nearly 20
- INSIDERLarge owner Squadron Capital Llc sold $6,352,773 worth of shares (302,369 units at $21.01) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Pritzker Jennifer N. sold $6,352,773 worth of shares (302,369 units at $21.01) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERDirector Pelizzon David R sold $6,352,773 worth of shares (302,369 units at $21.01) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Squadron Capital Llc sold $7,761,194 worth of shares (336,831 units at $23.04) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Pritzker Jennifer N. sold $7,761,194 worth of shares (336,831 units at $23.04) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERDirector Pelizzon David R sold $7,761,194 worth of shares (336,831 units at $23.04) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Pritzker Jennifer N. sold $943,302 worth of shares (38,300 units at $24.63) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Squadron Capital Llc sold $943,302 worth of shares (38,300 units at $24.63) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERDirector Pelizzon David R sold $943,302 worth of shares (38,300 units at $24.63) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- PROrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful ImplantationsWARSAW, Ind., Aug. 25, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics) (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the full commercial launch of its 3P™ Pediatric Plating Platform® Hip System. Following a highly successful limited launch period that resulted in over 350 surgical implantations, the system is now broadly available to pediatric orthopedic surgeons throughout the United States. The 3P Hip System is the first system within the Company's broader Pediatric Plating Platform portfolio and represents a significant advancement in trauma and deformity correction. "The response to the 3P Hip System du
- SECSEC Form 10-Q filed by OrthoPediatrics Corp.10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial GuidanceWARSAW, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2026. Second Quarter 2026 and Business Highlights Helped a record of nearly 46,000 children in the second quarter of 2026Generated new record high total revenue of $70.5 million for the second quarter of 2026, up 15% from $61.1 million in the second quarter of 2025; domestic revenue increased 14% and international revenue increased 22% in the quarterGrew worldwide Trauma & Deformity revenue 26% in the second q
KIDS FAQ
11 questionsWhat does OrthoPediatrics Corp. do?
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica...What is the latest news on KIDS?
In the last 30 days Quantisnow tracked 9 wire items for KIDS: 4 press releases and news items, 3 SEC filings and 2 earnings updates. The most recent was published on November 2, 2026.What is KIDS revenue?
OrthoPediatrics Corp. (KIDS) reported $264.14M of revenue for the twelve months ended Sep 30, 2026. That is up 16.1% from the year before. Revenue for fiscal 2025 was $236.35M.Is KIDS profitable?
No. OrthoPediatrics Corp. reported a net loss of $33.88M for the twelve months ended Sep 30, 2026.How much cash and debt does KIDS have?
OrthoPediatrics Corp. reported $17.14M in cash and cash equivalents and $101.13M of debt on its most recent balance sheet in SEC filings.Where does KIDS stock trade?
OrthoPediatrics Corp. (KIDS) is listed on NASDAQ.What sector and industry is KIDS in?
OrthoPediatrics Corp. operates in the Health Care sector, Medical/Dental Instruments industry.When did OrthoPediatrics Corp. go public?
OrthoPediatrics Corp. (KIDS) completed its IPO in 2017.What are analysts saying about KIDS?
Across the last 8 analyst actions on OrthoPediatrics Corp., there were 0 upgrades and 1 downgrade. The most recent action was from TD Cowen: Buy with a $23.00 price target on 2026-01-27. Recent price targets range from $23.00 to $77.00.What companies are similar to KIDS?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare KIDS side-by-side with any of them on Quantisnow.How can I track KIDS on Quantisnow?
Quantisnow aggregates OrthoPediatrics Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KIDS to receive live email and push alerts on every new disclosure.